With the recent good news about the Pfizer and Moderna Phase 3 trials exhibiting greater than 90% efficacy, what exactly does this mean and how does it compare to other vaccines? In this episode, we discuss the impact of these results and the next steps in the vaccine distribution process.
With the recent good news about the Pfizer and Moderna Phase 3 trials exhibiting greater than 90% efficacy, what exactly does this mean and how does it compare to other vaccines? In this episode, we discuss the impact of these results and the next steps in the vaccine distribution process.